Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)

China flag China · Delayed Price · Currency is CNY
12.64
-0.20 (-1.56%)
Apr 30, 2025, 3:00 PM CST
-35.41%
Market Cap 7.04B
Revenue (ttm) 3.42B
Net Income (ttm) 339.94M
Shares Out 557.12M
EPS (ttm) 0.60
PE Ratio 21.13
Forward PE 15.23
Dividend 0.37 (2.94%)
Ex-Dividend Date n/a
Volume 7,418,847
Average Volume 8,825,193
Open 12.70
Previous Close 12.84
Day's Range 12.55 - 12.80
52-Week Range 11.77 - 20.88
Beta 0.49
RSI 38.59
Earnings Date Jul 25, 2025

About SHA:600557

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 and is based in Lianyungang, China. [Read more]

Sector Healthcare
Founded 1975
Employees 5,443
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600557
Full Company Profile

Financial Performance

In 2024, SHA:600557's revenue was 3.90 billion, a decrease of -19.93% compared to the previous year's 4.87 billion. Earnings were 391.86 million, a decrease of -26.99%.

Financial Statements

News

There is no news available yet.